Tyra Biosciences Financials - Benzinga

Tyra Biosciences Inc

TYRANASDAQ

Trade with Public

Trade with Public

$24.86

-0.27-1.07%

At close: Sep 3, 5:00 PM EST

$24.40

-0.46-1.85%

After Hours: 4:22 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Tyra Biosciences Financials

Tyra Biosciences (TYRA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.65) by 6.15 percent. This is a 46.81 percent decrease over losses of $(0.47) per share

Benzinga Newsdesk

PRO
Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.47 percent. This is a 36.17 percent decrease over losses of $(0.47) per share from

Benzinga Newsdesk

PRO
Tyra Biosciences Q4 EPS $(0.57) Misses $(0.55) Estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 4.2 percent. This is a 32.56 percent decrease over losses of $(0.43) per share from

Benzinga Newsdesk

PRO
Tyra Biosciences Q3 EPS $(0.50), Inline

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.50) per share which met the analyst consensus estimate. This is a 21.95 percent decrease over losses of $(0.41) per share from the same period last year.

Benzinga Newsdesk

PRO
Tyra Biosciences Q2 EPS $(0.47) Beats $(0.53) Estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.53) by 11.15 percent. This is a 46.87 percent decrease over losses of $(0.32) per share from

Benzinga Newsdesk

PRO
Tyra Biosciences Q1 EPS $(0.47) Beats $(0.48) Estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 34.29 percent decrease over losses of $(0.35) per share from

Benzinga Newsdesk